Dermatologic outcomes associated with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a large-scale target trial emulation - Poll - MDSpire

Dermatologic outcomes associated with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a large-scale target trial emulation

  • By

  • Yi-Lun Chiang

  • Tzu-Hao Li

  • Yu-Wei Fang

  • Ya-Fang Liu

  • Jennifer Wu

  • Ming-Hsien Tsai

  • April 13, 2026

  • 0 min

Share

Original Source(s)

Dermatologic outcomes associated with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a large-scale target trial emulation

  • by Yi-Lun Chiang, Tzu-Hao Li, Yu-Wei Fang, Ya-Fang Liu, Jennifer Wu, Ming-Hsien Tsai

  • April 13, 2026

Related Content

The Role of SERPINA12 in Skin: Molecular Mechanisms and Its Involvement in Adipocyte Function, Psoriasis, and Palmoplantar Keratoderma

A Narrative Review: Do Systemic Drugs Used in the Treatment of Psoriatic Disease Affect Alzheimer’s Disease?

Obesity’s Cancer Role Underestimated

A proposed framework highlights potential sources of bias in current estimates